181 related articles for article (PubMed ID: 36558080)
41. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
42. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
[TBL] [Abstract][Full Text] [Related]
43. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
Song L; Coppola D; Livingston S; Cress D; Haura EB
Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661
[TBL] [Abstract][Full Text] [Related]
44. ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine.
Verma A; Yadav P; Rajput S; Verma S; Arora S; Kumar R; Bhatti JS; Khurana A; Navik U
Anticancer Agents Med Chem; 2023; 23(13):1587-1595. PubMed ID: 37046197
[TBL] [Abstract][Full Text] [Related]
45. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
46. Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
Meiler J; Guyot M; Hoffarth S; Wesarg E; Höhn Y; Breitenbuecher F; Schuler M
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1385-94. PubMed ID: 22488173
[TBL] [Abstract][Full Text] [Related]
47. Malayoside, a cardenolide glycoside extracted from Antiaris toxicaria Lesch, induces apoptosis in human non-small lung cancer cells via MAPK-Nur77 signaling pathway.
Hu QY; Zhang XK; Wang JN; Chen HX; He LP; Tang JS; Yao XS; Liu J
Biochem Pharmacol; 2021 Aug; 190():114622. PubMed ID: 34043967
[TBL] [Abstract][Full Text] [Related]
48. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
Amran N; Abdul-Rahman PS
J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
[TBL] [Abstract][Full Text] [Related]
49. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
50. LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells.
Qiang Y; Ma F; Wang Z; Nie Z; Xu L; Ding P; Ma X
Biochem Biophys Res Commun; 2020 Jan; 521(4):846-852. PubMed ID: 31708104
[TBL] [Abstract][Full Text] [Related]
51. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
52. Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells.
Vinod Prabhu V; Elangovan P; Niranjali Devaraj S; Sakthivel KM
Gene; 2018 Dec; 679():352-359. PubMed ID: 30218747
[TBL] [Abstract][Full Text] [Related]
53. Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases.
Ma L; Wang R; Nan Y; Li W; Wang Q; Jin F
Int J Oncol; 2016 Feb; 48(2):843-53. PubMed ID: 26692364
[TBL] [Abstract][Full Text] [Related]
54. Bishydroquinone Renieramycin M Induces Apoptosis of Human Lung Cancer Cells Through a Mitochondria-dependent Pathway.
Pinkhien T; Maiuthed A; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Anticancer Res; 2016 Dec; 36(12):6327-6333. PubMed ID: 27919953
[TBL] [Abstract][Full Text] [Related]
55. Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway.
Zou T; Gu L; Yang L; Wei J; Zhao Y; Shen J; Li M; Wu X; Du F; Chen Y; Ye Y; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2022; 17(4):396-409. PubMed ID: 35049438
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
57. Chemistry of Renieramycins. Part 19: Semi-Syntheses of 22-
Chamni S; Sirimangkalakitti N; Chanvorachote P; Suwanborirux K; Saito N
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32785022
[TBL] [Abstract][Full Text] [Related]
58. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells.
Liu Z; Sun Y; Ren L; Huang Y; Cai Y; Weng Q; Shen X; Li X; Liang G; Wang Y
BMC Cancer; 2013 Oct; 13():494. PubMed ID: 24156374
[TBL] [Abstract][Full Text] [Related]
60. Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in
Nangia V; Siddiqui FM; Caenepeel S; Timonina D; Bilton SJ; Phan N; Gomez-Caraballo M; Archibald HL; Li C; Fraser C; Rigas D; Vajda K; Ferris LA; Lanuti M; Wright CD; Raskin KA; Cahill DP; Shin JH; Keyes C; Sequist LV; Piotrowska Z; Farago AF; Azzoli CG; Gainor JF; Sarosiek KA; Brown SP; Coxon A; Benes CH; Hughes PE; Hata AN
Cancer Discov; 2018 Dec; 8(12):1598-1613. PubMed ID: 30254092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
